Dyvenpro Distribucion Y Venta DE Pharmaceutical Import Profile — Ecuador (DGFT 2022–2026)

Name: Dyvenpro Distribucion Y Venta DE Pharmaceutical Import Records from India — 10 Products, $16.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Dyvenpro Distribucion Y Venta DE — Pharmaceutical Importer Profile (2026) | 10 Products, $16.1M Trade | TransData Nexus

Dyvenpro Distribucion Y Venta DE

Pharmaceutical Importer · Ecuador · Antibiotics Focus · $16.1M Total Trade · DGFT Verified

Dyvenpro Distribucion Y Venta DE is a pharmaceutical importer based in Ecuador with a total trade value of $16.1M across 10 products in 6 therapeutic categories. Based on 344 verified import shipments from Indian Customs (DGFT) records, Dyvenpro Distribucion Y Venta DE is the #1 buyer in 1 product including Ambroxol. Dyvenpro Distribucion Y Venta DE sources from 4 verified Indian suppliers, with Wexford Laboratories Private Limited accounting for 92.3% of imports.

Dyvenpro Distribucion Y Venta DE — Import Portfolio & Supplier Network

Dyvenpro Distribucion Y Venta DE import network — 10 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Dyvenpro Distribucion Y Venta DE?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Wexford Laboratories Private Limited	$12.1M	876	92.3%
Sun Pharmaceutical Industries Limited	$569.0K	16	4.3%
Troikaa Pharmaceuticals Limited

What Formulations Does Dyvenpro Distribucion Y Venta DE Import?

Formulation	Value	Ships
Amoxicillin oral suspension BP 250MG/5ML	$682.2K	29
Clarithromycin tablets USP 500MG	$529.0K	14
Acetaminophen tablets USP 500MG	$469.4K	21
Loratadine tablets USP 10MG	$397.9K	19
Amoxicillin capsules BP 500MG	$377.0K	15
Omeprazole delayed - release capsules	$361.9K	15
Ibuprofen tablets BP 400MG	$356.7K	19
Amlodipine tablets 5MG	$334.8K	20
Ibuprofen tablets BP 600MG	$307.7K	17
Ambroxol syrup 15MG/5ML - expectuss -	$302.6K	12
Tranexamic acid injection BP 500MG/5ML	$301.6K	9
Enalapril maleate tablets USP 20MG	$269.4K	17
Cefadroxil capsules USP	$259.4K	12
Dicloxacillin sodium capsules USP 500MG	$257.0K	10
Metformin tablets BP 850MG	$233.9K	9

Dyvenpro Distribucion Y Venta DE imports 261 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 10 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ibuprofen	Analgesics & Antipyretics	$3.9M	77	0.7%	13
2	Amoxicillin	Antibiotics	$3.4M	67	0.5%	8
3	Loratadine	Antihistamines & Allergy	$1.9M	39	1.1%	3
4	Enalapril	Cardiovascular	$1.4M	27	0.6%	3
5	Ketorolac	Analgesics & Antipyretics	$1.1M	32	1.0%	17
6	Cephalexin	Antibiotics	$1.1M	21	0.3%	7
7	Ambroxol	Respiratory & OTC	$950.0K	19	6.4%	1
8	Fluconazole	Antifungals	$874.4K	20	1.0%	14
9	Clarithromycin	Antibiotics	$850.0K	17	0.9%	3
10	Levofloxacin	Antibiotics	$809.5K	25	1.1%	15

Dyvenpro Distribucion Y Venta DE imports 10 pharmaceutical products across 6 categories into Ecuador totaling $16.1M. The company is the #1 buyer for 1 product: Ambroxol.

Dyvenpro Distribucion Y Venta DE — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Dyvenpro Distribución y Venta de Productos Sociedad Anónima, commonly known as Dyvenpro, is a prominent pharmaceutical importer and distributor based in Guayaquil, Ecuador. Established on November 19, 1992, the company operates within the miscellaneous nondurable goods merchant wholesalers sector. Dyvenpro is a subsidiary of Grupo Difare, a leading conglomerate in the Ecuadorian pharmaceutical industry. The company specializes in the importation, wholesale distribution, and representation of a diverse range of pharmaceutical and consumer products, including over-the-counter (OTC) medications and health-related items. With a portfolio encompassing over 500 products and 220 brands, Dyvenpro has established itself as a key player in Ecuador's pharmaceutical supply chain.

2Distribution Network

Dyvenpro's distribution network is strategically designed to ensure efficient delivery of pharmaceutical products across Ecuador. The company's headquarters are located in Guayaquil, serving as the central hub for its operations. While specific details about warehouse locations and logistics capabilities are not publicly disclosed, Dyvenpro's affiliation with Grupo Difare suggests access to an extensive infrastructure that supports nationwide distribution. This infrastructure likely includes multiple warehouses and a robust logistics system capable of handling the importation and distribution of a wide array of pharmaceutical products. The company's geographic coverage extends throughout Ecuador, ensuring that its products are accessible to a broad consumer base.

3Industry Role

Dyvenpro plays a pivotal role in Ecuador's pharmaceutical supply chain as a primary wholesaler and distributor. By importing a diverse range of pharmaceutical products, including over-the-counter medications and health-related items, Dyvenpro ensures that these products are available to various stakeholders, including retail pharmacies, hospitals, and other healthcare providers. The company's operations are integral to the efficient functioning of the pharmaceutical market in Ecuador, facilitating the availability of essential medications and health products to the Ecuadorian population.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Dyvenpro Distribucion Y Venta DE

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Dyvenpro's sourcing strategy exhibits a significant concentration on a single supplier, Wexford Laboratories Private Limited, which accounts for 92.3% of the company's total import value from India. This heavy reliance on one supplier indicates a strategic choice aimed at achieving favorable terms, consistency in product quality, and streamlined logistics. However, such concentration also introduces potential risks, including supply chain disruptions in the event of issues with the primary supplier. The stability of this relationship is crucial for Dyvenpro's operations, and the company likely implements measures to mitigate risks associated with supplier dependency.

2Supply Chain Resilience

Dyvenpro's supply chain resilience is closely tied to its relationship with Wexford Laboratories Private Limited, the primary supplier of pharmaceutical products. The company's heavy reliance on this single supplier necessitates a robust risk management strategy to address potential disruptions. While the concentration may offer benefits such as favorable terms and consistent product quality, it also exposes Dyvenpro to risks associated with supply chain disruptions. The company likely monitors the stability and reliability of its primary supplier and may consider diversifying its supplier base to enhance supply chain resilience.

Importing Pharmaceuticals into Ecuador — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Ecuador

1Regulatory Authority & Framework

In Ecuador, the primary regulatory authority overseeing pharmaceutical imports is the Agencia Nacional de Regulación, Control y Vigilancia Sanitaria (ARCSA). ARCSA is responsible for ensuring the safety, efficacy, and quality of pharmaceutical products entering the Ecuadorian market. Key legislation governing pharmaceutical imports includes the Ley Orgánica de Salud and its associated regulations, which establish the framework for the importation, registration, and distribution of pharmaceutical products. The marketing authorization pathway for Indian generics involves obtaining product registration from ARCSA, which requires submission of comprehensive documentation, including evidence of product quality, safety, and efficacy.

2Import Licensing & GMP

Import licensing requirements in Ecuador mandate that all pharmaceutical products, including generics from India, must be registered with ARCSA prior to importation. This process involves submitting detailed product information, manufacturing site inspections, and compliance with Good Manufacturing Practice (GMP) standards. Ecuador recognizes GMP certificates from reputable authorities such as the European Union (EU GMP), World Health Organization (WHO GMP), and Pharmaceutical Inspection Co-operation Scheme (PIC/S). Indian exporters seeking to supply Dyvenpro and the broader Ecuadorian market must ensure that their manufacturing facilities hold valid GMP certifications from these recognized bodies. Additionally, obtaining wholesale distribution authorization from ARCSA is essential for legal distribution within Ecuador.

Dyvenpro Distribucion Y Venta DE — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Dyvenpro's product category focus on antibiotics, analgesics, antipyretics, antihistamines, and allergy medications aligns with prevalent health concerns in Ecuador. The significant importation of antibiotics and analgesics addresses the high demand for treatments related to infections and pain management. Antihistamines and allergy medications cater to the growing incidence of allergic reactions among the Ecuadorian population. This strategic focus enables Dyvenpro to meet critical healthcare needs and maintain a competitive edge in the pharmaceutical market.

2Sourcing Profile

Dyvenpro's sourcing strategy emphasizes the importation of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, primarily from India. This approach allows the company to offer a diverse range of products without the complexities associated with raw active pharmaceutical ingredients (APIs). India's established pharmaceutical manufacturing capabilities, adherence to international quality standards, and cost-effectiveness make it a preferred sourcing destination for Dyvenpro.

3Market Positioning

Seller's Guide — How to Become a Supplier to Dyvenpro Distribucion Y Venta DE

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Dyvenpro, especially if they can offer competitive pricing, consistent product quality, and reliable supply chain operations. Identifying gaps in Dyvenpro's current sourcing, such as unmet therapeutic needs or emerging market trends, could present avenues for new suppliers to introduce innovative products. Establishing a partnership with Dyvenpro would require a thorough understanding of Ecuadorian regulatory requirements and a commitment to maintaining high-quality standards.

2Requirements & Qualifications

Indian exporters aiming to supply Dyvenpro and the Ecuadorian market must ensure that their manufacturing facilities hold valid GMP certifications from recognized authorities such as the EU, WHO, or PIC/S. Additionally, compliance with Ecuadorian labeling requirements, including Spanish language labels and adherence to serialization mandates, is essential. Understanding and navigating the product registration process with ARCSA is crucial for market entry.

3How to Approach

Frequently Asked Questions — Dyvenpro Distribucion Y Venta DE

What products does Dyvenpro Distribucion Y Venta DE import from India?

Dyvenpro Distribucion Y Venta DE imports 10 pharmaceutical products across 6 categories. Top imports: Ibuprofen ($3.9M), Amoxicillin ($3.4M), Loratadine ($1.9M), Enalapril ($1.4M), Ketorolac ($1.1M).

Who supplies pharmaceuticals to Dyvenpro Distribucion Y Venta DE from India?

Dyvenpro Distribucion Y Venta DE sources from 4 verified Indian suppliers. The primary supplier is Wexford Laboratories Private Limited (92.3% of imports, $12.1M).

What is Dyvenpro Distribucion Y Venta DE's total pharmaceutical import value?

Dyvenpro Distribucion Y Venta DE's total pharmaceutical import value from India is $16.1M, based on 344 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Dyvenpro Distribucion Y Venta DE focus on?

Dyvenpro Distribucion Y Venta DE imports across 6 categories. The largest: Antibiotics (37.5%), Analgesics & Antipyretics (30.7%), Antihistamines & Allergy (12.1%).

Get Full Dyvenpro Distribucion Y Venta DE Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.